Mangrove Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,623	Closed	-$822K	–	160
2025 Q1	$822K	Buy	+11,623	New	+$822K	0.09%	81
2024 Q4	–	Sell	-10,334	Closed	-$726K	–	164
2024 Q3	$726K	Buy	+10,334	New	+$726K	0.06%	124